Inorganic Chemistry
Forum Article
mass spectrometry (MALDI-TOF MS) was recorded on a Bruker
Autoflex III smartbeam in reflectron and positive-ion mode.
opening was evidenced by the disappearance of the signal at 47
ppm and the concomitant appearance of signals at 36 and 37
ppm, corresponding to the two diastereomers of complex 5
(see the SI). Upon dissolution of the fully dried complex 5 in
CD2Cl2, the fully open complex 4a was regenerated, completing
the closing and reopening cycle. The 31P NMR spectrum of the
resulting product shows the disappearance of the resonances at
36 and 37 ppm and the reappearance of the signal at 1.8 ppm
(JP−Pt = 3740 Hz), consistent with the formation of the cis
Synthesis. Benzimidazolium Salt (1). In a modified procedure,30 a
solution of 1,4-bis[(chloromethyl)thio]benzene (50 mg, 0.209 mmol)
and 1-methylbenzimidazole (74.09 mg, 0.627 mmol) was dissolved in
5 mL of anhydrous dimethylformamide. The reaction mixture was
stirred and heated at 100 °C for 24 h in a Schlenk flask under N2 gas.
The solvent was reduced to ca. 1 mL in vacuo with heptane. The
product was then washed with diethyl ether (Et2O) and dichloro-
methane (CH2Cl2) and dried in vacuo to obtain a white solid (66.3
mg, 0.132 mmol, 63% yield). 1H NMR (400 MHz, DMSO-d6): δ 9.85
(s, 2H), 7.68 (dtd, J = 15.7, 7.4, and 6.3 Hz, 4H), 7.72−7.64 (m, 4H),
7.37 (s, 4H), 6.17 (s, 4H), 4.05 (s, 6H). 13C NMR (126 MHz, DMSO-
d6): δ 142.32, 132.31, 131.98, 131.67, 130.12, 126.79, 126.67, 114.06,
113.91, 49.83, 33.42.
CONCLUSIONS
■
Of the various supramolecular architectures that have been
synthesized through coordination-driven supramolecular as-
sembly, the macrocycle continues to be an important
architecture because of its defined cavity, making it useful for
host−guest chemistry, designed molecular recognition, and
catalysis.2 Additionally, macrocyclic architectures have paved
the way for the synthesis of larger, more sophisticated
structures with three-dimensional cavities. The addressable
construct described here is a potentially useful building block
for the construction of higher order, chemically addressable
complexes with multistate switching capabilities. Key to the
success of the stepwise formation of heteroligated WLA
macrocycles is the kinetic stability of the complexes where
the “weak-link” thioether is a relatively strong donor. The
consequence of this strong bonding is illustrated by the
formation of the semiopen/fully closed complex 6, in which a
MeOH molecule occupies one of the empty coordination sites.
The MeOH molecule displaces a single thioether and alleviates
some of the fully closed structure’s strain energy, which has
been investigated by DFT calculations. The ring strain present
in this system suggests that the WLA may allow us to design
systems in which strain can be exploited to enable the use of
allosteric effectors that are not anionic. The result is a
macrocyclic structure that can adopt new intermediate states
previously not observed in traditional WLA systems, making it
the first platinum-based system to require multiple cues or
stimuli to be switched between states and the only known four-
state WLA system.
[Pt2Cl4(κ1:μ:κ1-NHC,S)(C2H6OS)2] (2-DMSO). A solution of benzi-
midazolium salt (1) (100 mg, 0.199 mmol) in a solvent mixture of
CH2Cl2/MeOH at a ratio of 6:1 (4 mL) was combined with Ag2O (46
mg, 0.199 mmol), and the mixture was stirred at 60 °C until the
solution became murky and the black Ag2O powder disappeared. After
10 min, a solution of PtCl2(cod) (149 mg, 0.397 mmol) in the solvent
mixture of CH2Cl2/MeOH at a ratio of 6:1 (6 mL) was added to the
mixture, which was then stirred at 60 °C over 24 h. The suspension
was centrifuged, washed with Et2O (10 mL × 3), and dried in vacuo.
The product was obtained as an off-white powder (115 mg, 0.120
1
mmol, 60% yield). H NMR (400 MHz, DMSO-d6): δ 7.74 (dd, J =
8.2 and 3.7 Hz, 2H), 7.41 (d, J = 1.7 Hz, 4H), 7.35 (t, J = 7.7 Hz, 2H),
7.29−7.16 (m, 4H), 6.20−6.02 (m, 4H), 4.19 (d, J = 3.6 Hz, 6H). 13C
1
NMR (126 MHz, DMSO-d6): δ 155.68 (d, JC−Pt = 4.2 Hz), 133.17
(s), 133.05 (s), 132.73 (s), 132.66 (s), 124.02 (s), 123.89 (s), 111.69
(s), 111.36 (s), 111.31 (s), 51.37 (s), 34.83 (s). MALDI-TOF MS
(matrix: dithranol). Calcd for [M − Cl]+: m/z 926.961. Found: m/z
926.803.
1,4-Bis(diphenylphosphino)ethylthiobenzene (3). In a modified
procedure,42,43 benzene-1,4-dithiol (0.340 mg, 2.36 mmol) was
combined with azobis(isobutyronitrile) (catalytic amount) in a
Schlenk flask in THF (15 mL) under N2 gas. Diphenylvinylphosphine
(KPPh2; 1.0 g, 4.71 mmol) was added dropwise to the reaction
mixture, via a syringe, under N2 gas over the course of 30 min. The
solution turned from yellow to red. The reaction was refluxed for 18 h
under N2 gas. After stirring for 18 h, the reaction solution was
concentrated in vacuo to give a yellow oil. The crude product was
washed with hexanes (10 mL × 3) followed by MeOH (10 mL × 3),
filtered, and dried under high vacuum. The pure product appeared as
1
an off-white solid powder (1.18 g, 90% yield). H NMR (400 MHz,
CD2Cl2): δ 7.41−7.35 (m, 8H), 7.34−7.31 (m, 12H), 7.10 (s, 4H),
2.96−2.90 (m, 4H), 2.36−2.32 (m, 4H). 31P NMR (162 MHz,
CD2Cl2): δ −17.36.
EXPERIMENTAL SECTION
■
General Methods/Instrument Details. Commercially available
chemicals were purchased as reagent grade from Sigma-Aldrich, Acros,
and Alfa Aesar, unless otherwise noted, and used as received. Unless
otherwise stated, all solvents were purchased anhydrous and degassed
under a stream of argon prior to use. All glassware and magnetic
stirring bars were thoroughly dried in an oven (180 °C). Reactions
were monitored using thin-layer chromatography (TLC), commercial
TLC plates (silica gel 254, Merck Co.) were developed, and the spots
were visualized under UV light at 254 or 365 nm. Flash
chromatography was performed using SiO2-60 (230−400 mesh
ASTM, 0.040−0.063 mm; Fluka). Deuterated solvents were purchased
[cis-Pt2Cl4(κ1:μ:κ1-NHC,S)(κ1:μ:κ1-P,S)], [trans-Pt2Cl4(κ1:μ:κ1-
NHC,S)(κ1:μ:κ1-P,S)], and [cis-PtCl2(κ1:μ:κ1-NHC,S)(κ1:μ:κ1-P,S)-trans-
PtCl2(κ1:μ:κ1-NHC,S)(κ1:μ:κ1-P,S)] (4a−4c). A solution of 3 (81.3 mg,
0.143 mmol) in CD2Cl2/CD3OD (1:1, 2.5 mL) was added to a
suspension of complex 2 (115 mg, 0.120 mmol) in CD2Cl2/CD3OD
(1:1, 0.7 mL) in a glass vial in the glovebox. The mixture was then
stirred at room temperature for 48 h, during which the yellow murky
solution became clear and a dark precipitate formed (AgCl). The
supernatant was then dried in vacuo to obtain a pale-yellow solid
1
powder as the product (114 mg, 0.0745 mmol, 62% yield). H NMR
from Cambridge Isotope Laboratories and used as received. H, 31P,
1
(400 MHz, CD2Cl2): δ 8.06−6.95 (m, 38H), 4.27−3.82 (m, 4H),
3.35−3.10 (br, 8H), 1.26 (s, 6H). 31P NMR (162 MHz, CD2Cl2): δ
10.45 (d, 1JP−Pt = 2270 Hz); 9.73 (d, 1JP−Pt = 2300 Hz); 2.53 (d, 1JP−Pt
31P{1H}, and 19F{1H} NMR spectra were recorded on a Bruker
Avance 400 MHz spectrometer, and chemical shifts (δ) are given in
parts per million. 1H NMR spectra were referenced internally to
residual proton resonances in the deuterated solvents (dichloro-
methane-d2 = δ 5.32; nitromethane-d3 = δ 4.33; methanol-d4 = δ 3.31).
31P and 31P{1H} NMR spectra were referenced to an external 85%
H3PO4 standard (δ 0). High-resolution mass spectrometry (HRMS)
measurements were recorded on an Agilent 6120 LC-TOF instrument
in positive-ion mode. Electrospray ionization mass spectrometry (ESI-
MS) was recorded on a Micromas Quatro II triple−quadrapole mass
spectrometer. Matrix-assisted laser desorption/ionization time-of-flight
1
= 2943 Hz); 1.81 (d, JP−Pt = 3740 Hz). HRMS (ESI+). Calcd for [M
− Cl]+: m/z 1493.1039. Found: m/z 1493.1051.
[cis-Pt2Cl4(κ1:μ:κ1-NHC,S)(κ1:μ:κ1-P,S)] (4a). Crystals of complex 4a
were obtained by the slow diffusion of Et2O into a CH2Cl2 solution of
4a−4c. 1H NMR (400 MHz, CD2Cl2): δ 8.06−8.00 (m, 4H), 7.75 (s,
4H), 7.60−7.48 (m, 10H), 7.35 (s, 4H), 7.30−7.11 (m, 11H), 7.01−
6.98 (m, 9H), 6.03−5.84 (d, 13.54 Hz, 2H), 5.78−5.57 (d, 13.51 Hz,
2H), 3.82 (s, 6H), 3.45−3.22 (dt, 6.16, 6.16, 11.32 Hz, 4H), 3.19−2.92
(m, 4H). 31P NMR (162 MHz, CD2Cl2): δ 1.84 (1JP−Pt = 3740 Hz).
I
Inorg. Chem. XXXX, XXX, XXX−XXX